{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Livonia",
      "state": "MI",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78162",
      "recalling_firm": "The Harvard Drug Group",
      "address_1": "17177 N Laurel Park Dr Ste 233",
      "address_2": "",
      "postal_code": "48152-3951",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0013-2018",
      "product_description": "Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa 403 722 INDIA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ  07054; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-5858-61.",
      "product_quantity": "3,935 cartons",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.",
      "recall_initiation_date": "20170926",
      "center_classification_date": "20171019",
      "termination_date": "20200429",
      "report_date": "20171025",
      "code_info": "Lot 1274C151A, Exp 10/17",
      "more_code_info": ""
    }
  ]
}